These results clearly indicated that PM protects against pathological cardiac hypertrophy by reducing the nuclear translocation of p‐STAT3 and inhibiting the JAK2/STAT3 signalling pathway. The gene discussed is JAK2; the disease is cardiac hypertrophy.